Mesenchymal Stem Cells in Fibrotic Disease

doi:10.1016/j.stem.2017.07.011

Review

. 2017 Aug 3;21(2):166-177.

doi: 10.1016/j.stem.2017.07.011.

Mesenchymal Stem Cells in Fibrotic Disease

Elie El Agha¹, Rafael Kramann², Rebekka K Schneider³, Xiaokun Li⁴, Werner Seeger⁵, Benjamin D Humphreys⁶, Saverio Bellusci⁷

Affiliations

¹ Institute of Life Sciences, Wenzhou University, Wenzhou University-Wenzhou Medical University Collaborative Innovation Center of Biomedicine, Wenzhou, Zhejiang, China; Excellence Cluster Cardio-Pulmonary System (ECCPS), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen, Germany. Electronic address: elie.el-agha@innere.med.uni-giessen.de.
² Division of Nephrology and Clinical Immunology, Medical Faculty RWTH Aachen University, RWTH Aachen University, Aachen, Germany.
³ Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University, Aachen, Germany.
⁴ Institute of Life Sciences, Wenzhou University, Wenzhou University-Wenzhou Medical University Collaborative Innovation Center of Biomedicine, Wenzhou, Zhejiang, China.
⁵ Excellence Cluster Cardio-Pulmonary System (ECCPS), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen, Germany; Max Planck Institute for Heart and Lung Research, W.G. Kerckhoff Institute, Bad Nauheim, Germany.
⁶ Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, USA.
⁷ Institute of Life Sciences, Wenzhou University, Wenzhou University-Wenzhou Medical University Collaborative Innovation Center of Biomedicine, Wenzhou, Zhejiang, China; Excellence Cluster Cardio-Pulmonary System (ECCPS), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen, Germany. Electronic address: saverio.bellusci@innere.med.uni-giessen.de.

PMID: 28777943
DOI: 10.1016/j.stem.2017.07.011

Free article

Review

Mesenchymal Stem Cells in Fibrotic Disease

Elie El Agha et al. Cell Stem Cell. 2017.

Free article

. 2017 Aug 3;21(2):166-177.

doi: 10.1016/j.stem.2017.07.011.

Authors

Elie El Agha¹, Rafael Kramann², Rebekka K Schneider³, Xiaokun Li⁴, Werner Seeger⁵, Benjamin D Humphreys⁶, Saverio Bellusci⁷

Affiliations

¹ Institute of Life Sciences, Wenzhou University, Wenzhou University-Wenzhou Medical University Collaborative Innovation Center of Biomedicine, Wenzhou, Zhejiang, China; Excellence Cluster Cardio-Pulmonary System (ECCPS), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen, Germany. Electronic address: elie.el-agha@innere.med.uni-giessen.de.
² Division of Nephrology and Clinical Immunology, Medical Faculty RWTH Aachen University, RWTH Aachen University, Aachen, Germany.
³ Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University, Aachen, Germany.
⁴ Institute of Life Sciences, Wenzhou University, Wenzhou University-Wenzhou Medical University Collaborative Innovation Center of Biomedicine, Wenzhou, Zhejiang, China.
⁵ Excellence Cluster Cardio-Pulmonary System (ECCPS), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen, Germany; Max Planck Institute for Heart and Lung Research, W.G. Kerckhoff Institute, Bad Nauheim, Germany.
⁶ Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, USA.
⁷ Institute of Life Sciences, Wenzhou University, Wenzhou University-Wenzhou Medical University Collaborative Innovation Center of Biomedicine, Wenzhou, Zhejiang, China; Excellence Cluster Cardio-Pulmonary System (ECCPS), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen, Germany. Electronic address: saverio.bellusci@innere.med.uni-giessen.de.

PMID: 28777943
DOI: 10.1016/j.stem.2017.07.011

Abstract

Fibrosis is associated with organ failure and high mortality and is commonly characterized by aberrant myofibroblast accumulation. Investigating the cellular origin of myofibroblasts in various diseases is thus a promising strategy for developing targeted anti-fibrotic treatments. Recent studies using genetic lineage tracing technology have implicated diverse organ-resident perivascular mesenchymal stem cell (MSC)-like cells and bone marrow-MSCs in myofibroblast generation during fibrosis development. In this Review, we give an overview of the emerging role of MSCs and MSC-like cells in myofibroblast-mediated fibrotic disease in the kidney, lung, heart, liver, skin, and bone marrow.

Keywords: lineage tracing; mesenchymal stem cells; organ fibrosis.

PubMed Disclaimer

Cited by

Mi-BMSCs alleviate inflammation and fibrosis in CCl₄-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling.
Shi Q, Xia Y, Wu M, Pan Y, Wu S, Lin J, Kong Y, Yu Z, Zan X, Liu P, Xia J. Shi Q, et al. Mater Today Bio. 2024 Jan 24;25:100958. doi: 10.1016/j.mtbio.2024.100958. eCollection 2024 Apr. Mater Today Bio. 2024. PMID: 38327975 Free PMC article.
Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis.
Su DN, Wu SP, Xu SZ. Su DN, et al. Stem Cell Res Ther. 2020 Sep 14;11(1):395. doi: 10.1186/s13287-020-01911-4. Stem Cell Res Ther. 2020. PMID: 32928296 Free PMC article.
The Emerging Role of Extracellular Vesicles from Mesenchymal Stem Cells and Macrophages in Pulmonary Fibrosis: Insights into miRNA Delivery.
Li S, Zhang J, Feng G, Jiang L, Chen Z, Xin W, Zhang X. Li S, et al. Pharmaceuticals (Basel). 2022 Oct 17;15(10):1276. doi: 10.3390/ph15101276. Pharmaceuticals (Basel). 2022. PMID: 36297388 Free PMC article. Review.
Transcriptional analysis of lung fibroblasts identifies PIM1 signaling as a driver of aging-associated persistent fibrosis.
Pham TX, Lee J, Guan J, Caporarello N, Meridew JA, Jones DL, Tan Q, Huang SK, Tschumperlin DJ, Ligresti G. Pham TX, et al. JCI Insight. 2022 Mar 22;7(6):e153672. doi: 10.1172/jci.insight.153672. JCI Insight. 2022. PMID: 35167499 Free PMC article.
Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves' Orbitopathy.
Wang X, Ye H, Yang S, Sha X, Wang X, Zhang T, Chen R, Xiao W, Yang H. Wang X, et al. Int J Mol Sci. 2022 May 9;23(9):5261. doi: 10.3390/ijms23095261. Int J Mol Sci. 2022. PMID: 35563653 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 HL086322/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Mesenchymal Stem Cells in Fibrotic Disease

Affiliations

Mesenchymal Stem Cells in Fibrotic Disease

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources